A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: lacking (201), not including (1000)

Dexamethasone(40)-Pomalidomide

Description
Regimen Chemotherapy Protocol Myeloma Dexamethasone (40)-Pomalidomide • Myeloma – Dexamethasone (40)-Pomalidomide Indication • Pomalido
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/Dexamethasone-40-Pomalidomide.pdf

Dexamethasone(20)-Pomalidomide

Description
Chemotherapy Protocol Myeloma Dexamethasone (20)-Pomalidomide Regimen • Myeloma – Dexamethasone (20)-Pomalidomide Indication • Pomalido
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/Dexamethasone-20-Pomalidomide.pdf

Clarithromycin-Dexamethasone_40_Pomalidomide

Description
Chemotherapy Protocol Myeloma Clarithromycin-Dexamethasone (40)-Pomalidomide Regimen • Myeloma – Clarithromycin-Dexamethasone (40)-Poma
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/Clarithromycin-Dexamethasone-40-Pomalidomide.pdf

Clarithromycin-Dexamethasone_20_Pomalidomide

Description
Chemotherapy Protocol Myeloma Clarithromycin-Dexamethasone (20)-Pomalidomide Regimen • Myeloma – Clarithromycin-Dexamethasone (20)-Poma
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/Clarithromycin-Dexamethasone-20-Pomalidomide.pdf

Dry eyes - patient information

Description
Without enough tears, small patches on the front window of your eye (the cornea) can dry out.
Url
/Media/UHS-website-2019/Patientinformation/Eyes/Dry-eyes-1387-PIL.pdf

Child protection and safeguarding - patient information

Description
Child protection and safeguarding Information for parents, carers and guardians Child protection at Southampton Children’s Ho
Url
/Media/UHS-website-2019/Patientinformation/Childhealth/Child-protection-and-safeguarding-2197-PIL.pdf

Health and safety policy

Description
Health and Safety Policy Date Issued: 21/11/18 Review Date: 21/11/21 Document Type: Policy Version: 10.0 Contents Paragraph 1 2 3 4
Url
/Media/UHS-website-2019/Docs/Policies/Health-and-safety-policy.pdf

Supplier representative procedure

Description
Procurement and supply chain and the commercial development team appreciate the role that companies play to assist the Trust in providing
Url
/Media/UHS-website-2019/Docs/Policies/Supplier-representative-procedure.pdf

IdelalisibRituximab

Description
Chemotherapy Protocol Chronic Lymphocytic Leukaemia (CLL) Idelalisib-Rituximab Regimen • CLL – Idelalisib-Rituximab Indication • Chronic lymphoc
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/IdelalisibRituximab.pdf

Paclitaxel (7 day)

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER PACLITAXEL (7 day) Regimen • Ovary – Paclitaxel (7 day) Indication • Second or subsequent lin
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/Paclitaxel-7-day.pdf
141 to 150 of 1000
Previous … 13 14 15 16 17 … Next